<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-01T09:43:14+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【Lancet Oncol】KATE2研究：T-DM1联合阿替利珠单抗对比T-DM1治疗HER2+晚期乳腺癌</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/h1iV6SZUNCynzZRCMsYOnA</id>
    <link href="https://mp.weixin.qq.com/s/h1iV6SZUNCynzZRCMsYOnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>掌握肿瘤“风向标”  把控肺癌治疗先机</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Zyav_gpU2lN_moEwW1lI1g</id>
    <link href="https://mp.weixin.qq.com/s/Zyav_gpU2lN_moEwW1lI1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海市抗癌协会多原发和不明原发肿瘤专业委员会成立</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/jRTYEIJExH4dkNgmtvsnsg</id>
    <link href="https://mp.weixin.qq.com/s/jRTYEIJExH4dkNgmtvsnsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>C对话 | 第四期：梁逸歆教授答王晰程教授，析少见突变结直肠癌临床治疗难题</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/8ihBPwS8gAV_kK2oFL5Xag</id>
    <link href="https://mp.weixin.qq.com/s/8ihBPwS8gAV_kK2oFL5Xag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】朱正飞教授：肺癌精准治疗理念，颠覆国内新药研发思路和环境</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/eA_EZZqrMRT3bXqQj5JKnQ</id>
    <link href="https://mp.weixin.qq.com/s/eA_EZZqrMRT3bXqQj5JKnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>姚煜教授：引领生存新高度，纳武利尤单抗二线治疗驱动基因阴性晚期NSCLC标准地位难以撼动</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/xsCkHCe0GCot6wW2syqu1w</id>
    <link href="https://mp.weixin.qq.com/s/xsCkHCe0GCot6wW2syqu1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新合作，发展共赢，第十届泌尿肿瘤国际论坛暨CACA-GU、CSCO-PC 2020年会大幕将启</title>
    <updated>2020-11-30T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/ZvmHdwQcEZgQrhHuQ5cyuA</id>
    <link href="https://mp.weixin.qq.com/s/ZvmHdwQcEZgQrhHuQ5cyuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO Asia | CDK4/6抑制剂探索HR+乳腺癌辅助治疗，monarchE研究能否改变临床实践？</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/FChKcvnu61YO9lYzj2gwig</id>
    <link href="https://mp.weixin.qq.com/s/FChKcvnu61YO9lYzj2gwig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>徐波教授：明确发展目标，积极谋划智能肿瘤学学科发展</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/p8H9wYsb_3HgBv1JtjjH-A</id>
    <link href="https://mp.weixin.qq.com/s/p8H9wYsb_3HgBv1JtjjH-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】韩宝惠教授专访：抗血管生成治疗在晚期NSCLC治疗中的非凡意义</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/_BPETpgNiE-H2ahp4TyMvQ</id>
    <link href="https://mp.weixin.qq.com/s/_BPETpgNiE-H2ahp4TyMvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO Asia丨Futibatinib 用于伴FGFR2融合/重排的肝内胆管癌，前景可观</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/u8HEjQTlAXeGz9oGBOi3Yg</id>
    <link href="https://mp.weixin.qq.com/s/u8HEjQTlAXeGz9oGBOi3Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【JCO】ARTSCAN Ⅲ：顺铂联合放疗对比西妥昔单抗联合放疗于局部晚期头颈部鳞状细胞癌患者有更好的疗效</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/1lyDvRwe8PVZ2gKqI6eOdA</id>
    <link href="https://mp.weixin.qq.com/s/1lyDvRwe8PVZ2gKqI6eOdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia 2020】KRAS：不可成药的靶点是否已被攻克？</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/lQ0fQ9ITpPNvSuWo1cFLZA</id>
    <link href="https://mp.weixin.qq.com/s/lQ0fQ9ITpPNvSuWo1cFLZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO ASIA】林榕波教授团队氢吗啡酮PCA（患者自控镇痛技术）静脉滴定治疗重度癌痛更新研究成果！</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/anA9_VOfCc2dOlQTal7_tA</id>
    <link href="https://mp.weixin.qq.com/s/anA9_VOfCc2dOlQTal7_tA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】王佳蕾教授：十五年风雨兼程，多学科综合协作理念与机制“双轨并行”</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/9Z4fWUnb7TIyyyZz8Otc1A</id>
    <link href="https://mp.weixin.qq.com/s/9Z4fWUnb7TIyyyZz8Otc1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia 2020】洞悉真实世界MET基因异常晚期NSCLC的临床特征及治疗现状</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/Nt9oi78hniApfCeS7KNiJg</id>
    <link href="https://mp.weixin.qq.com/s/Nt9oi78hniApfCeS7KNiJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议预告】中国消化道肿瘤免疫治疗学术论坛-2020 POST ESMO (11月29日)</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/1o7h9JKiZBO0R7GLMO_ozQ</id>
    <link href="https://mp.weixin.qq.com/s/1o7h9JKiZBO0R7GLMO_ozQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周琦教授：子宫肉瘤备受关注，影像新技术或可破解诊疗困境</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/TtIX8aZzfqJpicWcKsu7OA</id>
    <link href="https://mp.weixin.qq.com/s/TtIX8aZzfqJpicWcKsu7OA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陆舜教授分享EGFR克隆性前瞻性研究成果，分子克隆影响靶向治疗疗效</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/P1LRDhaZjJC8JUJF6TI43Q</id>
    <link href="https://mp.weixin.qq.com/s/P1LRDhaZjJC8JUJF6TI43Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】陈海泉教授：关注影像随访，注重全程管理，磨玻璃结节无需闻之色变</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Yv1hhVCX3Dnuh5v84WHw-Q</id>
    <link href="https://mp.weixin.qq.com/s/Yv1hhVCX3Dnuh5v84WHw-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>